7-(4-(4-(23 Dichlorophenyl)piperazin-1 yl)butoxy)quinolin-2(1H)-one PurReagent
PurReagent
Properties
| Vapour pressure | No data available |
| Autoignition temp. | No data available |
| Explosion limit | No data available |
| Assay Purity | ?99.5% |
| Refractive index | No data available |
| B pt. | 654.4±55.0 °C |
| M pt. | >139oC(dec.) |
| Density | 1.281±0.06 g/cm3 |
Safety Information
| Hazard Statement(s) | H225,H290,H301 + H311 + H331,H370 |
| Precautionary Statement | P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311 |
| Symbol | |
| Signal word | Danger |
| HS Code | 29337900 |
| Storage Temp. | 2-8°C |
| Storage Class | 3 - Flammable liquids |
| UN Number | 3249 |
Description
Application
It is used primarily for managing psychiatric disorders especially in patients who may not be able to take oral forms of aripiprazole. Dehydro aripiprazole solution is often administered intravenously in a hospital or clinical environment for faster absorption and efficacy.
Purpose
For R&D
General Description
Dehydro aripiprazole solution is a metabolite of aripiprazole an atypical antipsychotic medication commonly used for treating conditions such as schizophrenia and bipolar disorder. This solution is typically used in clinical settings where a more immediate form of medication is required.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |
